IBUPROFEN
- Product NDC
- 41226-601
- Requested package NDC
- 41226-601-05
- 11-digit product format
- 412260601
- Labeler code
- 41226
- Product ID
- 41226-601_3f89772f-94d8-4e14-e063-6294a90a769b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- IBUPROFEN
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Kroger Company
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-04-10
- Substance
- IBUPROFEN
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- IBUPROFEN
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WK2XYI10QM | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310965 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| bbedfc37-913d-8046-e053-2995a90af68a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41226-601-01 | IBUPROFEN | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 41226-601-01 | IBUPROFEN | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 41226-601-05 | IBUPROFEN | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 41226-601-05 | IBUPROFEN | 50 in 1 BOTTLE | TABLET, COATED | 50 | 6 | |
| 41226-601-10 | IBUPROFEN | 2 in 1 PACKAGE, COMBINATION | TABLET, COATED | 2 | 6 | |
| 41226-601-20 | IBUPROFEN | 200 in 1 BOTTLE | TABLET, COATED | 200 | 6 | |
| 41226-601-25 | IBUPROFEN | 250 in 1 BOTTLE | TABLET, COATED | 250 | 6 | |
| 41226-601-42 | IBUPROFEN | 24 in 1 BOTTLE | TABLET, COATED | 24 | 6 | |
| 41226-601-42 | IBUPROFEN | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 41226-601-53 | IBUPROFEN | 500 in 1 BOTTLE | TABLET, COATED | 500 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin Low Dose | ASPIRIN | Meijer Distribution, Inc. | 3716a7d4-a555-4e54-aa0a-7b8f3e32addb | 2026-06-19 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | DOLGENCORP, LLC | acc94a3e-21b6-4375-9881-38cf9bab8692 | 2026-06-19 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | L.N.K. International, Inc. | 2f6ec676-3832-420e-be91-fce83f6586c8 | 2026-06-19 | Warnings | M013 |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | DOLGENCORP, LLC | e1e24d52-0b4d-400b-8181-e3f6ab75c4f6 | 2026-06-18 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Oncor Pharmaceuticals | 4c396d0e-aa93-4f9e-b065-2e606f7f05cd | 2026-06-17 | Warnings | M013 |
| LOW DOSE ASPIRIN | ASPIRIN | Famora Inc. | 4dc6f119-bbde-db5f-e063-6294a90a9486 | 2026-06-16 | Warnings | M013 |
| Childrens Pain and Fever Relief | ACETAMINOPHEN | Chain Drug Marketing Association, Inc. | 420a1e05-caa6-481f-bdab-a670f0220f96 | 2026-06-16 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | DOLGENCORP, LLC | ce9f4e0d-43fb-499a-b8a2-a997a14841c4 | 2026-06-16 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | L.N.K. International, Inc. | 734cc3d2-6fc5-4dcc-93ed-0b57c1f01345 | 2026-06-15 | Warnings | M013 |
| RIGHT REMEDIES EXTRA STRENGTH Pain Relief PM Caplet | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Strive Pharmaceuticals Inc. | 2d63671d-cf7c-bbdd-e063-6294a90affef | 2026-06-15 | Warnings | M013 |
| TYLENOL Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | 59773893-09a8-47a2-943a-e9ea9da4458a | 2026-06-15 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | Shield Pharmaceuticals Corp. | 96eb7f9f-ff2d-4661-bbe6-1860aafe03f6 | 2026-06-15 | Warnings | M013 |
| Duralgina Extra Strength | ACETAMINOPHEN | Menper Distributors, Inc. | 544e3d7e-a759-384f-e063-6294a90a5baa | 2026-06-15 | Warnings | M013 |
| pain relief childrens | ACETAMINOPHEN | Rite Aid Corporation | be2286a1-946b-4bf5-b14c-8e86da669594 | 2026-06-15 | Warnings | M013 |
| Aspirin 81 | ASPIRIN | Amerisource Bergen | 4491faca-f30b-4eb0-bea9-f518f6b2f095 | 2026-06-15 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | P & L Development, LLC | 55e996cd-ef22-4e09-a05c-8aa994e4540b | 2026-06-12 | Warnings | M013 |
| CHILDRENS TYLENOL | ACETAMINOPHEN | Kenvue Brands LLC | 3162733b-9382-39f1-e063-6294a90ac420 | 2026-06-12 | Warnings | M013 |
| Acetaminophen Extra Strength | ACETAMINOPHEN | Dr. Reddy's Laboratories Inc. | 9769e0c0-2f4c-3b7a-1a65-c98fbce11681 | 2026-06-12 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | NuCare Pharmaceuticals, Inc. | 54010ddf-25d1-2016-e063-6294a90a877d | 2026-06-11 | Warnings | M013 |
| ACETAMINOPHEN | ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 983debdf-4a61-4dde-ba34-567fdd17720e | 2026-06-11 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310965 | ibuprofen 200 MG Oral Tablet | PSN | bbedfc37-913d-8046-e053-2995a90af68a | 6 |
| 310965 | ibuprofen 200 MG Oral Tablet | SCD | bbedfc37-913d-8046-e053-2995a90af68a | 6 |
| 310965 | ibuprofen 200 MG (as ibuprofen sodium 256 MG) Oral Tablet | SY | bbedfc37-913d-8046-e053-2995a90af68a | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 41226-601-05 | 41226060105 | 1 BOTTLE in 1 CARTON (41226-601-05) / 50 TABLET, COATED in 1 BOTTLE | 1 bottle | 2021-06-12 | 0000-00-00 | No | No | Current |